Coronary plaque disruption

Circulation

Volumn 92, Issue 3, 1995, Pages 657-671

  Falk, Erling ^a   Shah, Prediman K ^b   Fuster, Valentin ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; CORONARY ARTERY ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; HEART MUSCLE ISCHEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCLEROSIS; SHEAR STRESS; THROMBOSIS;

EID: 0029090411     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.3.657     Document Type: Review

References (266)

1. Fuster V, Badimon L, Badimon J, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
2. Fuster V. Lewis A. Conner Memorial Lecture: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
3. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions. Circulation. 1989;80:198-205.
4. Shah PK, Forrester JS. Pathophysiology of acute coronary syndromes. Am J Cardiol. 1991;68(suppl C):16C-23C.
5. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989; 63(suppl E):114E-120E.
6. Fernández-Ortiz A, Badimon J, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
7. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
8. Falk E. Why do plaques rupture? Circulation. 1992;86(suppl III): III-30-III-42.
9. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol. 1993;143:496-506.
10. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Am J Pathol. 1994;144:952-961.
11. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171:223-229.
12. Faruqi RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J. 1993;69(suppl):S19-S29.
13. Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J. 1993;69(suppl): S38-S41.
14. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 1991;88:5252-5256.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
16. Rekhter MD, Gordon D. Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res. 1994;75:410-417.
17. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
18. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Särkioja T, Witztum JL, Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest. 1991;87: 1146-1152.
19. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344:793-795.
20. Demer LL, Watson KE, Boström K. Mechanism of calcification in atherosclerosis. Trends Cardiovasc Med. 1994;4:45-49.
21. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995; 91:2488-2496.
22. Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis. 1994;105:1-7.
23. Falk E, Fernández-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol. 1995;75:1B-7B.
24. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation. 1989;80:1747-1756.
25. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol. 1990;66: 562-567.
26. Rosenschein U, Ellis SG, Yakubov SJ, Haudenschild CC, Dick RJ, Topol EJ. Histopathologic correlates of coronary lesion angiographic morphology: lessons from a directional atherectomy experience. Coron Artery Dis. 1992;3:953-961.
27. Lundberg B. Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis. 1985;56:93-110.
28. Small DM. Progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis. 1988;8: 103-129.
29. Tracy RE, Devaney K, Kissling G. Characteristics of the plaque under a coronary thrombus. Virchows Arch A Pathol Anat. 1985; 405:411-427.
30. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
31. Guyton JR, Klemp KF. Transitional features in human atherosclerosis: intimai thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Pathol. 1993;143:1444-1457.
32. Guyton JR, Klemp KF. Development of the atherosclerotic core region: chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Artenoscler Thromb. 1994;14:1305-1314.
33. Wissler RW, the PDAY collaborating investigators. New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Atherosclerosis. 1994;108(suppl):S3-S20.
34. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis. 1989;9:1-20.
35. Baroldi G, Silver MD, Mariani F, Giuliano G. Correlation of morphological variables in the coronary atherosclerotic plaque with clinical patterns of ischemic heart disease. Am J Cardiovasc Pathol. 1988;2:159-172.
36. Hangartner JRW, Charleston AJ, Davies MJ, Thomas AC. Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J. 1986;56:501-508.
37. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED, Killip T, Sosa JA, Bourassa MG, CASS Participating Investigators and Staff. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1993;22: 1141-1154.
38. Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Kim K, Shindo T, Kimura K. Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol. 1991;18:904-910.
39. Giroud D, Li JM, Urban P, Meier B, Rutishauser W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol. 1992;69: 729-732.
40. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12: 56-62.
41. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157-1166.
42. Danchin N. Is myocardial revascularisation for tight coronary stenoses always necessary? Lancet. 1993;342:224-225. Viewpoint.
43. MAAS investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet. 1994;344: 633-638.
44. Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial. Stroke. 1994;25:304-308.
45. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
46. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
47. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833-843.
48. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. 1983;3:187-198.
49. Reed DM, Strong JP, Resch J, Hayashi T. Serum lipids and lipoproteins as predictors of atherosclerosis: an autopsy study. Arteriosclerosis. 1989;9:560-564.
50. Robertson WB, Strong JP. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:538-551.
51. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report. JAMA. 1990;264:3018-3024.
52. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY study. Arterioscler Thromb. 1993;13:1291-1298.
53. Devries S, Wolfkiel C, Fusman B, Bakdash H, Ahmed A, Levy P, Chomka E, Kondos G, Zajac E, Rich S. Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. J Am Coll Cardiol. 1995;25:76-82.
54. Dollar AL, Kragel AH, Fernicola DJ, Waclawiw MA, Roberts WC. Composition of atherosclerotic plaques in coronary arteries in women <40 years of age with fatal coronary artery disease and implications for plaque reversibility. Am J Cardiol. 1991;67: 1223-1227.
55. Gertz SD, Malekzadeh S, Dollar AL, Kragel AH, Roberts WC. Composition of atherosclerotic plaques in the four major epicardial coronary arteries in patients ≥90 years of age. Am J Cardiol. 1991;67:1228-1233.
56. Kragel AH, Roberts WC. Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia. Am Heart J. 1991;121:210-211.
57. Mautner SL, Lin F, Roberts WC. Composition of atherosclerotic plaques in the epicardial coronary arteries in juvenile (type I) diabetes mellitus. Am J Cardiol. 1992;70:1264-1268.
58. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50:127-134.
59. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 1989;2:941-944.
60. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
61. Frink RJ. Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. J Invasive Cardiol. 1994;6: 173-185.
62. Gertz SD, Roberts WC. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 1990;66: 1368-1372.
63. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
64. Wagner WD, St Clair RW, Clarkson TB, Connor JR. A study of atherosclerosis regression in Macaca mulatto, III: chemical changes in arteries from animals with atherosclerosis induced for 19 months and regressed for 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Am J Pathol. 1980;100: 633-650.
65. Loree HM, Tobias BJ, Gibson LJ, Kamm RD, Small DM, Lee RT. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb. 1994;14:230-234.
66. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 1992;71:850-858.
67. Burleigh MC, Briggs AD, Lendon CL, Davies MJ, Born GV, Richardson PD. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis. 1992;96:71-81.
68. Majno G, Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
69. Lee RT, Grodzinsky AJ, Frank EH, Kamm RD, Schoen FJ. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation. 1991;83: 1764-1770.
70. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1966;6:1-17.
71. Friedman M. The coronary thrombus: its origin and fate. Hum Pathol. 1971;2:81-128.
72. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
73. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis. 1991;87:87-90.
74. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
75. Matrisian LM. The matrix degrading metalloproteinases. Bioessays. 1992;14:455-463.
76. Shah PK, Falk E, Badimon JJ, Levy G, Fernandez-Ortiz A, Fallon J, Fuster V. Human monocyte-derived macrophages express collagenase and induce collagen breakdown in atherosclerotic fibrous caps: implications for plaque rupture. Circulation. 1993;88(suppl I):I-254. Abstract.
77. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix degrading metalloproteinases and implications for plaque rupture. Circulation. In press.
78. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
79. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix-metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
80. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995;91:2125-2131.
81. Rennick RE, Ling KLE, Humphries SE, Henney AM. Effect of acetyl-LDL on monocyte/macrophage expression of matrix metalloproteinases. Atherosclerosis. 1994;109(suppl):192. Abstract.
82. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
83. Jude B, Agraou B, McFadden EP, Susen S, Bauters C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation. 1994;90:1662-1668.
84. Leatham EW, Bath PMW, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995;73:10-13.
85. Neri Serneri GG, Gensini GF, Poggesi L, Modesti PA, Rostagno C, Boddi M, Gori AM, Martini F, Ieri A, Margheri M, Abbate R. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes. Coron Artery Dis. 1994;5:137-145.
86. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90: 1669-1678.
87. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994;25: 154-159.
88. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989; 320:365-376.
89. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
90. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation. 1991;84:1758-1772.
91. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol. 1993;22:1228-1241. Review article.
92. Fitzgerald JD. By what means might beta blockers prolong life after acute myocardial infarction? Eur Heart J. 1987;8:945-951.
93. Lee RT, Kamm RD. Vascular mechanics for the cardiologist. J Am Coll Cardiol. 1994;23:1289-1295.
94. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation. 1993;87:1179-1187.
95. Leary T. Coronary spasm as a possible factor in producing sudden death. Am Heart J. 1934;10:338-344.
96. Lin CS, Penha PD, Zak FG, Lin JC. Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of atheromatous plaque caused by coronary artery spasm. Angiology. 1988(June):535-547.
97. Etsuda H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Isojima K. Angioscopy in variant angina: coronary artery spasm and intimai injury. Lancet. 1993;342:1322-1324.
98. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 1994;90:5-11.
99. Lam JY, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation. 1987;76: 243-248.
100. 2 and serotonin are possible mediators. Circulation. 1989;79:154-166.
101. Zeiher AM, Schächinger V, Weitzel SH, Wollschläger H, Just H. Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circulation. 1991;83:1519-1525.
102. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65:1299-1306.
103. Kaski JC, Tousoulis D, McFadden E, Crea F, Pereira WI, Maseri A. Variant angina pectoris: role of coronary spasm in the development of fixed coronary obstructions. Circulation. 1992;85: 619-626.
104. Barger AC, Beeuwkes R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310:175-177.
105. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimai microvessels in coronary atherosclerosis. Am J Pathol. 1993;143:164-172.
106. Barger AC, Beeuwkes R. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol. 1990;66(suppl G):41G-43G.
107. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310: 1137-1140.
108. Constantinides P. Cause of thrombosis in human atherosclerotic arteries. Am J Cardiol. 1990;66(suppl G):37G-40G.
109. Aoki T, Ku DN. Collapse of diseased arteries with eccentric cross section. J Biomech. 1993;26:133-142.
110. Mizushige K, Reisman M, Buchbinder M, Dittrich H, DeMaria AN. Atheroma deformation during the cardiac cycle: evaluation by intracoronary ultrasound. Circulation. 1993;88(suppl I):I-550. Abstract.
111. Alfonso F, Macaya C, Goicolea J, Hernandez R, Segovia J, Zamorano J, Banuelos C, Zarco P. Determinants of coronary compliance in patients with coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 1994;23:879-884.
112. Stein PD, Hamid MS, Shivkumar K, Davis TP, Khaja F, Henry JW. Effects of cyclic flexion of coronary arteries on progression of atherosclerosis. Am J Cardiol. 1994;73:431-437.
113. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018-1031.
114. Gibson CM, Diaz L, Kandarpa K, Sacks FM, Pasternak RC, Sandor T, Feldman C, Stone PH. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb. 1993;13:310-315.
115. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ Res. 1993;72:239-245.
116. Gertz SD, Uretzky G, Wajnberg RS, Navot N, Gotsman MS. Endothelial cell damage and thrombus formation after partial arterial constriction: relevance to the role of coronary artery spasm in the pathogenesis of myocardial infarction. Circulation. 1981;63:476-486.
117. Gould KL. Collapsing coronary stenosis: a Starling resistor. Int J Cardiol. 1982;2:39-42.
118. Binns RL, Ku DN. Effect of stenosis on wall motion: a possible mechanism of stroke and transient ischemic attack. Arteriosclerosis. 1989;9:842-847.
119. Loree HM, Kamm RD, Atkinson CM, Lee RT. Turbulent pressure fluctuations on surface of model vascular stenoses. Am J Physiol. 1991;261:H644-H650.
120. Svindland A, Torvik A. Atherosclerotic carotid disease in asymptomatic individuals: a histological study of 53 cases. Acta Neurol Scand. 1988;78:506-517.
121. Bassiouny HS, Davis H, Massawa N, Gewertz BL, Glagov S, Zarins CK. Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg. 1989;9:202-212.
122. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79: 733-743.
123. Willich SN, Maclure M, Mittleman M, Arntz H-R, Muller JE. Sudden cardiac death: support for a role of triggering in causation. Circulation. 1993;87:1442-1450.
124. Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol. 1994;23:809-813.
125. Willich SN, Collins R, Peto R, Linderer T, Sleight P, Schröder R, ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. Eur Heart J. 1992;13: 594-598.
126. Gnecchi-Ruscone T, Piccaluga E, Guzzetti S, Contini M, Montano N, Nicolis E. Morning and Monday: critical periods for the onset of acute myocardial infarction: the GISSI 2 Study Experience. Eur Heart J. 1994;15:882-887.
127. Goldberg RJ, Brady P, Muller JE, Chen ZY, de Groot M, Zonneveld P, Dalen JE. Time of onset of symptoms of acute myocardial infarction. Am J Cardiol. 1990;66:140-144.
128. Willich SN, Löwel H, Lewis M, Hörmann A, Arntz H, Keil U. Weekly variation of acute myocardial infarction: increased Monday risk in the working population. Circulation. 1994;90: 87-93.
129. Ornato JP, Siegel L, Craren EJ, Nelson N. Increased incidence of cardiac death attributed to acute myocardial infarction during winter. Coron Artery Dis. 1990;1:199-203.
130. Douglas AS, al Sayer H, Rawles JM, Allan TM. Seasonality of disease in Kuwait. Lancet. 1991;337:1393-1397.
131. Marchant B, Ranjadayalan K, Stevenson R, Wilkinson P, Timmis AD. Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: the influence of environmental temperature. Eur Heart J. 1994;25(abstract suppl):473. Abstract.
132. Trichopoulos D, Katsouyanni K, Zavitsanos X, Tzonou A, Dalla Vorgia P. Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet. 1983;1:441-444.
133. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chetboun I, Arbel Y, David D. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet. 1991;338:660-661.
134. Gelernt MD, Hochman JS. Acute myocardial infarction triggered by emotional stress. Am J Cardiol. 1992;69:1512-1513.
135. Jacobs SC, Friedman R, Mittleman M, Maclure M, Sherwood J, Benson H, Muller JE. 9-fold increased risk of myocardial infarction following psychological stress as assessed by a casecontrol study. Circulation. 1992;86(suppl I):I-198. Abstract.
136. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med. 1993;329:1677-1683.
137. Willich SN, Lewis M, Löwel H, Arntz H-R, Schubert F, Schröder R. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 1993;329:1684-1690.
138. Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, Robertson T, Antman EM, Muller JE, and the MILIS Study Group. Analysis of possible triggers of acute myocardial infarction (the MILIS Study). Am J Cardiol. 1990;66:22-27.
139. Curfman GD. Is exercise beneficial-or hazardous-to your heart? N Engl J Med. 1993;329:1730-1731. Editorial.
140. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams G, Muller JE. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987; 316:1514-1518.
141. Ridker PM, Manson JE, Buring JE, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation. 1990;82:897-902.
142. Grignani G, Soffiantino F, Zucchella M, Pacchiarini L, Tacconi F, Bonomi E, Pastoris A, Sbaffi A, Fratino P, Tavazzi L. Platelet activation by emotional stress in patients with coronary artery disease. Circulation. 1991;83(suppl II):II-128-II-136.
143. Hjemdahl P, Chronos NA, Wilson DJ, Bouloux P, Goodall AH. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb. 1994;14:77-84.
144. Prisco D, Paniccia R, Guarnaccia V, Olivo G, Taddei T, Boddi M, Gensini GF. Thrombin generation after physical exercise. Thromb Res. 1993;69:159-164.
145. Andreotti F, Davies GJ, Hackett DR, Khan MI, DeBart ACW, Aber VR, Maseri A, Kluft C. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol. 1988;62:635-637.
146. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 1989;79:101-106.
147. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J. 1993;69:121-124.
148. Quyyumi AA, Panza JA, Diodati JG, Lakatos E, Epstein SE. Circadian variation in ischemic threshold: a mechanism underlying the circadian variation in ischemic events. Circulation. 1992;86: 22-28.
149. Yusuf S, Peto J, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
150. Loaldi A, Polese A, Montorsi P, De Cesare N, Fabbiocchi F, Ravagnani P, Guazzi MD. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol. 1989;64:433-439.
151. Hjemdahl P, Larsson PT, Wallen NH. Effects of stress and betablockade on platelet function. Circulation. 1991;84(suppl VI): VI-44-VI-61.
152. Wright RA, Perrie AM, Stenhouse F, Alberti KGMM, Riemersma RA, MacGregor IR, Boon NA. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease. Eur J Clin Pharmacol. 1994;46:279-282.
153. Heintzen MP, Strauer BE. Peripheral vascular effects of beta-blockers. Eur Heart J. 1994;15(suppl C):2-7.
154. Leren P. Ischaemic heart disease: how well are the risk profiles modulated by current beta blockers? Cardiology. 1993;82(suppl 3):8-12.
155. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R, and the ISAM Study Group. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior β-adrenergic blockade. Circulation. 1989;80: 853-858.
156. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57(suppl F):43F-49F.
157. The Danish Study Group on Verapamil in Myocardial Infarction. The effect of verapamil on mortality and major events after myocardial infarction: the Danish Verapamil Infarction Trial II (DAVIT II). Am J Cardiol. 1990;66:779-785.
158. Pahor MP, The CRIS Investigators. Secondary prevention of myocardial infarction with verapamil: Calcium Antagonist Reinfarction Italian Study (CRIS). Eur Heart J. 1994;15(abstract suppl):134. Abstract.
159. Held PH, Yusuf S. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Coron Artery Dis. 1994;5: 21-26.
160. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 1993;88:1502-1511.
161. Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994;89:1951-1957.
162. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J. 1994; 128:7-11.
163. Winniford MD, Wheelan KR, Kremers MS, Ugolini V, van den Berg E Jr, Niggemann EH, Jansen DE, Hillis LD. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation. 1986;73:662-667.
164. Moliterno DJ, Willard JE, Lange RA, Negus BH, Boehrer JD, Glamann DB, Landau C, Rossen JD, Winniford MD, Hillis LD. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330:454-459.
165. Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan HM. Intracoronary ultrasound imaging: correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol. 1993;21:35-44.
166. Ge J, Erbel R, Gerber T, Gorge G, Koch L, Haude M, Meyer J. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J. 1994;71: 572-578.
167. Baptista J, de Feyter P, di Mario C, Escaned J, Serruys PW. Stable and unstable anginal syndromes: target lesion morphology prior to coronary interventions using angiography, intra-coronary ultrasound and angioscopy. Eur Heart J. 1994;15(abstract suppl):321. Abstract.
168. Nesto RW, Sassower MA, Manzo KS, Bymes CM, Friedl SE, Muller JE, Abela GS. Angioscopic differentiation of culprit lesions in unstable versus stable coronary artery disease. J Am Coll Cardiol. 1993;21(suppl A):195A. Abstract.
169. Merickel MB, Berr S, Spetz K, Jackson TR, Snell J, Gillies P, Shimshick E, Hainer J, Brookeman JR, Ayers CR. Noninvasive quantitative evaluation of atherosclerosis using MRI and image analysis. Arterioscler Thromb. 1993;13:1180-1186.
170. Toussaint J-F, Southern JF, Falk E, Fuster V, Kantor HL. Atherosclerotic plaque components imaged by nuclear magnetic resonance. Circulation. 1993;88(suppl I):I-520. Abstract.
171. 13C-NMR spectroscopy of human atherosclerotic lesions: relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. Arterioscler Thromb. 1994;14:1951-1957.
172. Baraga JJ, Feld MS, Rava RP. In situ optical histochemistry of human artery using near infrared Fourier transform Raman spectroscopy. Proc Natl Acad Sci U S A. 1992;89:3473-3477.
173. Vallabhajosula S, Paidi M, Badimon JJ, Le NA, Goldsmith SJ, Fuster V, Ginsberg HN. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med. 1988;29:1237-1245.
174. 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988;8: 461-470.
175. 99mTc-labeled monoclonal antiplatelet antibody S12: preliminary experience in human percutaneous transiuminal angioplasty. Circulation. 1992;85: 1354-1363.
176. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
177. Wada H, Mori Y, Kaneko T, Wakita Y, Nakase T, Minamikawa K, Ohiwa M, Tamaki S, Tanigawa M, Kageyama S, Deguchi K, Nakano T, Shirakawa S, Suzuki K. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol. 1993;44:112-116.
178. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Caligiuri G, Monaco C, Rebuzzi AG, Bizzi RB, Maseri A. Neutrophil activation in unstable angina and acute myocardial infarction is a possible marker of inflammation and of disease activity. Eur Heart J. 1994;15(abstract suppl):472. Abstract.
179. Lam JY, Latour JG, Lesperance J, Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol. 1994;73:333-338.
180. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
181. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076-1079.
182. Herren T, Stricker H, Haeberli A, Do DD, Straub PW. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation. 1994;90:2679-2686.
183. Fowkes FG, Lowe GD, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 1993;342:84-86.
184. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation. 1993;88:2030-2034.
185. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165-1168.
186. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90:2236-2240.
187. Bruschke AVG, Kramer JR, Bal ET, Haque IU, Detrano RC, Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J. 1989;117:296-305.
188. Flugelman MY, Virmani R, Correa R, Yu Z-X, Farb A, Leon MB, Elami A, Fu Y-M, Casscells W, Epstein SE. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993;88:2493-2500.
189. Annex BH, Denning SM, Channon KM, Sketch MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91: 619-622.
190. Bogaty P, Hackett D, Davies GJ, Maseri A. Vasoreactivity at culprit lesions. Circulation. 1995;91:563-564. Letter.
191. Davies MJ, Bland JM, Hangartner JRW, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J. 1989;10: 203-208.
192. ElFawal MA, Berg GA, Wheatley DJ, Harland WA. Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br Heart J. 1987;57:329-335.
193. Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cordiol. 1991;17:1138-1142.
194. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
195. Ellis S, Alderman E, Cain K, Fisher L, Sanders W, Bourassa M, and the CASS Investigators. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS registry study. J Am Coll Cardiol. 1988;11:908-916.
196. Ellis S, Alderman EL, Cain K, Wright A, Bourassa M, Fisher L. Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry study. J Am Coll Cardiol. 1989;13:1481-1491.
197. White HD, French JK, Hamer AW, Brown MA, Williams BF, Ormiston JA, Cross DB. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol. 1995;25:218-223.
198. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. J Am Coll Cardiol. 1994;24:1091-1094.
199. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost. 1993;70:119-123.
200. Wilhelmsen L. Thrombocytes and coronary heart disease. Circulation. 1991;84:936-938. Editorial.
201. Prins MH, Hirsh J. A critical review of the relationship between impaired fibrinolysis and myocardial infarction. Am Heart J. 1991; 122:545-551.
202. Lo Y-SA, Cutler JE, Blake K, Wright AM, Kron J, Swerdlow CD. Angiographic coronary morphology in survivors of cardiac arrest. Am Heart J. 1988;115:781-785.
203. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
204. Bissett JK, Ngo WL, Wyeth RP, Matts JP, and the POSCH Group. Angiographic progression to total coronary occlusion in hyperlipidemic patients after acute myocardial infarction. Am J Cardiol. 1990;66:1293-1297.
205. Armstrong ML, Megan MB. Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets. Circ Res. 1972;30:675-680.
206. Armstrong ML, Megan MB. Arterial fibrous proteins in cynomolgus monkeys after atherogenic and regression diets. Circ Res. 1975;36:256-261.
207. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 1984;73:1590-1605.
208. Williams JK, Armstrong ML, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis. Circ Res. 1988;62:515-523.
209. Kaplan JR, Manuck SB, Adams MR, Williams JK, Register TC, Clarkson TB. Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment. Arterioscler Thromb. 1993;13:254-263.
210. Benzuly KH, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation. 1994;89:1810-1818.
211. Heistad DD, Armstrong ML. Sick vessel syndrome: can atherosclerotic arteries recover? Circulation. 1994;89:2447-2450. Editorial.
212. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1234-1241.
213. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. J Clin Invest. 1994; 94:155-164.
214. Leth-Espensen P, Stender S, Ravn H, Kjeldsen K. Anti-atherogenic effect of olive and corn oils in cholesterol-fed rabbits with the same plasma cholesterol levels. Arteriosclerosis. 1988;8: 281-287.
215. Kramsch DM, Aspen AJ, Abramowitz BM, Kreimendahl T, Hood WB. Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on an atherogenic diet. N Engl J Med. 1981;305:1483-1489.
216. Kaplan JR, Pettersson K, Manuck SB, Olsson G. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation. 1991;84(suppl VI):VI-23-VI-32.
217. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl 5):S65-S72.
218. Chobanian AV, Brecher PI, Haudenschild CC. Effects of hypertension and of antihypertensive therapy on atherosclerosis. Hypertension. 1986;8(suppl I):I-15-I-21.
219. Williams JK, Adams MR, Herrington DM, Clarkson TB. Shortterm administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452-457.
220. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
221. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993; 87:1781-1791.
222. Waters D, Craven TE, Lespérance J. Prognostic significance of progression of coronary atherosclerosis. Circulation. 1993;87: 1067-1075.
223. Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Pearce MB, Bissett JK, Edmiston WA, Sawin HS, Weber FJ, Varco RL, Campbell GS, Yellin AE, Smink RD, Long JM, Hansen BJ, Chalmers TC, Meier P, Stamler J, for the Program on the Surgical Control of the Hyperlipidemias (POSCH) Group. Changes in sequential coronary arteriograms and subsequent coronary events. JAMA. 1992;268:1429-1433.
224. Cashin-Hemphill L, Mack W, LaBree L, Hodis HN, Shircore A, Selzer RH, Blankenhorn DH. Coronary progression predicts future cardiac events. Circulation. 1993;88(suppl I):I-363. Abstract.
225. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
226. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992;340:1173-1178.
227. Pfeffer MA, Braunwald E, on behalf of SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
228. Rutherford JD, Pfeffer MA, Moyé LA, Davies BR, Flaker GC, Kowey PR, Lamas GA, Miller HS, Packer M, Rouleau JL, Braunwald E, on behalf of the SAVE Investigators. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement trial. Circulation. 1994; 90:1731-1738.
229. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056-2069.
230. Hodis HN, Mack WJ, LaBree L, Hemphill LC, Azen SP. Natural antioxidant vitamins reduce coronary artery lesion progression as assessed by sequential coronary angiography. J Am Coll Cardiol. 1994;23(suppl A):481A. Abstract.
231. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hâdell K, Johansson J, Kaijser L, Lassvik C, Mölgaard J, Nilsson S, Schäfer-Elinder L, Stenport G, Holme I. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol. 1994;74:875-883.
232. Master AM. The role of effort and occupation (including physicians) in coronary occlusion. JAMA. 1960;174:84-90.
233. Hambrecht R, Niebauer J, Marburger C, Grunze M, Kalberer B, Hauer K, Schlierf G, Kubler W, Schuler G. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol. 1993;22: 468-477.
234. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538-545.
235. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med. 1994;330:1549-1554.
236. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990;132: 612-628.
237. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80:234-244.
238. Rodriguez BL, Curb JD, Burchfiel CM, Abbott RD, Petrovitch H, Masaki K, Chiu D. Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men: the Honolulu Heart Program. Circulation. 1994; 89:2540-2544.
239. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals. American Heart Association Medical/Scientific Statement. Circulation. 1992;86:1664-1669.
240. Deckers JW, Agema WRP, Huijibrechts IPAM, Erdman RAM, Boersma H, Roelandt JRTC. Quitting of smoking in patients with recently established coronary artery disease reduces mortality by over 40%: results of a meta-analysis. Eur Heart J. 1994;15(abstract suppl):171. Abstract.
241. Shah PK, Helfant RH. Smoking and coronary artery disease. Chest. 1988;94:449-452.
242. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W, the INTACT Study Group. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: relation to clinical events and risk factors. Circulation. 1992;86:828-838.
243. Waters D, Higginson L, Gladstone P, Boccuzzi S, Cook T, Lespérance J. Smoking accelerates the progression of coronary atherosclerosis as assessed by serial quantitative coronary arteriography. Circulation. 1993;88(suppl I):I-344. Abstract.
244. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985;313:1511-1514.
245. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med. 1990;322:213-217.
246. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J. 1987;113:1006-1010.
247. Gomez MA, Karagounis LA, Allen A, Anderson JL, TEAM-2 Investigators. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction: Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction. Am J Cardiol. 1993;72:373-378.
248. Grines CL, Topol EJ, O'Neill WW, George BS, Kereiakes D, Phillips HR, Leimberger JD, Woodlief LH, Califf RM. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 1995;91:298-303.
249. Zahger D, Cercek B, Cannon CP, Jordan M, Davis V, Braunwald E, Shah PK, for the TIMI-4 Investigators. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am J Cardiol. 1995;75:232-236.
250. Khosla S, Laddu A, Ehrenpreis S, Somberg JC. Cardiovascular effects of nicotine: relation to deleterious effects of cigarette smoking. Am Heart J. 1994;127:1669-1672.
251. Roald HE, Orvim U, Bakken IJ, Barstad RM, Kierulf P, Sakariassen KS. Modulation of thrombotic responses in moderately Stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler Thromb. 1994;14:617-621.
252. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332: 1198-1203.
253. Muller JE, Tofler GH. Triggering and hourly variation of onset of arterial thrombosis. Ann Epidemiol. 1992;2:393-405.
254. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 1993;87:1969-1973.
255. Wright RA, Flapan AD, Alberti KG, Ludlam CA, Fox KA. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol. 1994;24:67-73.
256. Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH. Low-dose aspirin therapy for chronic stable angina: a randomized, placebo-controlled clinical trial. Ann Intern Med. 1991;114: 835-839.
257. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet. 1992;340:1421-1425.
258. Théroux P, Waters D, Qiu S, McCans J, Guise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 1993;88:2045-2048.
259. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993;341:1496-1500.
260. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latin R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation. 1994;89:1530-1538.
261. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolcmia. Circulation. 1994;89: 2519-2524.
262. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
263. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
264. Hunt BJ. The relation between abnormal hemostatic function and the progression of coronary disease. Curr Opin Cardiol. 1990;5: 758-765.
265. Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels: in vivo study in the rabbit model. Arterioscler Thromb. 1991;11: 395-402.
266. Lam JYT, Lacoste L. Hypercholesterolaemia and platelet thrombosis under arterial flow conditions. Eur Heart J. 1994; 15(abstract suppl):488. Abstract.